Promo !

Retatrutide 10mg

Le prix initial était : $150.00.Le prix actuel est : $125.00.

Retatrutide 10mg is an investigational once-weekly injectable triple hormone receptor agonist developed by Eli Lilly. It targets GLP-1, GIP, and glucagon receptors. Clinical trials show it produces exceptional weight loss—averaging up to 28% to 30% of body weight—alongside improvements in blood sugar and liver fat. It is not yet publicly approved or available.

Catégorie :

Retatrutide 10mg research-grade lyophilized peptide powder in a glass vial. Retatrutide (LY3437943), marketed here as Reta-Solution, is an investigational multi-receptor peptide agonist that targets the receptors for GIP, GLP-1 and glucagon, and is used in experimental models of obesity, glycemic control and metabolic regulation.

Research Use Only: All products are intended exclusively for laboratory and scientific research. Not for human or veterinary use.

 

Purity
99%+ (HPLC, third-party tested)

 

Form
Lyophilized peptide powder

 

Content
10 mg Retatrutide per vial

 

Packaging
Glass vial with sterile closure

 

Storage
Store lyophilized at 2–8 °C (desiccated, protect from light)

 

Molecular formula
C221 H342 N46 O68

 

Molecular weight
~4731.4 g·mol⁻¹

 

Sequence
Multidomain incretin/glucagon analog (GIP/GLP-1/glucagon triple agonist) peptide backbone with C20 fatty diacid and γGlu–(AEEA)2 side chain for extended PK (Retatrutide, LY3437943).

 

CAS number
2381089-83-2

Retatrutide 10mg

 

Research Overview

Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously. It is used in laboratory and preclinical models to study integrated control of body weight, glucose homeostasis and whole-body energy balance, without implying any therapeutic or clinical use.

Primary Research Areas

  • Triple GIP/GLP-1/glucagon receptor agonism: Mechanistic studies dissecting receptor pharmacology, biased signaling and downstream pathways triggered by combined incretin and glucagon receptor activation.
  • Obesity & body-weight regulation models: In vivo models exploring changes in body weight, adiposity, food intake and energy expenditure under Retatrutide-driven multi-agonist signaling.
  • Glycemic control & metabolic health: Research focused on glucose tolerance, insulin dynamics, hepatic glucose output and broader metabolic homeostasis in preclinical systems.
Reconstitution

Recommended solvent — Bacteriostatic water

Bacteriostatic water 10ml

For diluting lyophilized peptide powders, use a sterile and suitable research solvent such as bacteriostatic water (BAC), which may help support handling stability and reduce contamination risk.

For convenient laboratory use, see Bacteriostatic water 10ml.

What are the risks of using retatrutide?

Retatrutide 10mg is an investigational triple-hormone receptor agonist (GLP-1, GIP, and glucagon) that is still undergoing clinical trials and is not yet FDA-approved. Its primary risks include common dose-dependent gastrointestinal side effects, temporary increases in heart rate, unusual skin sensations, and the severe dangers tied to sourcing unverified black-market peptides.

GoodRx +6
Common and Distinct Side Effects
  • Gastrointestinal distress: Nausea (affecting up to 60% of users at higher doses), vomiting, diarrhea, and constipation occur as digestion slows.
    GoodRx +1
  • Dysesthesia: A unique side effect linked to retatrutide is temporary, unusual skin sensitivity or painful tingling and burning sensations (reported in up to 21% of high-dose trial participants).
    Lola Health +1
  • Heart rate elevation: Clinical studies show a temporary, dose-dependent increase in resting heart rate that typically peaks around week 24 before declining back toward baseline.
    Lola Health
Serious Potential Complications
  • Pancreatitis and gallbladder issues: Like other incretin-based medications, it carries a potential risk of acute inflammation of the pancreas (pancreatitis) or gallbladder problems like gallstones.
    GoodRx +1
  • Unregulated black-market use: Because the drug is not commercially available, buying “research-grade” or compounded retatrutide online introduces severe risks of incorrect dosing, contamination, counterfeiting, and a complete lack of medical supervision

Why Limitless Biochem?

Limitless BioChem is a trusted supplier of research compounds. Our products meet strict quality standards and are compliant with EU requirements. We focus on the safe and reliable supply of peptides and pure compounds intended exclusively for research or collector purposes.

This product is not intended for human or veterinary use. It is for collection or research purposes only. It cannot be used as food, dietary supplement or medicine! The information provided in the text on this page is for educational purposes only and does not constitute medical or other advice.

Avis

Il n’y a pas encore d’avis.

Soyez le premier à laisser votre avis sur “Retatrutide 10mg”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Panier

Save to list